(Q68952678)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

title

Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

author name string

D A Amato

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

E C Borden

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

M Shiraki

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

H T Enterline

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

C Rosenbaum

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

H L Davis

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

A R Paul

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

C M Stevens

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

H J Lerner

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

publication date

1 January 1985

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

Investigational New Drugs

28 September 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

volume

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

page(s)

397-401

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00170765

28 September 2019

exact match

0 references

cites work

A clinical review of bleomycin--a new antineoplastic agent

1 reference

12 December 2020

Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tissue and bone sarcoma group

1 reference

12 December 2020

Mode of action of the antitumor compound bruceantin, an inhibitor of protein synthesis

1 reference

12 December 2020

Phase I–II trial of intramuscularly administered bleomycin

1 reference

12 December 2020

Bruceantin, a new potent antileukemic simaroubolide from Brucea antidysenterica

1 reference

12 December 2020

A comparison of adriamycin versus vincristine and adriamycin, and cyclophosphamide versus vincristine, actinomycin-D, and cyclophosphamide for advanced sarcoma

1 reference

12 December 2020

DNA synthesis in HeLa cells and isolated nuclei after treatment with an inhibitor of spermidine synthesis, methyl glyoxal bis(guanylhydrazone)

1 reference

12 December 2020

The randomization and stratification of patients to clinical trials

1 reference

12 December 2020

Tumor inhibitors. 100. Isolation and structural elucidation of bruceantin and bruceantinol, new potent antileukemic quassinoids from Brucea antidysenterica

1 reference

12 December 2020

Pharmacology of chlorozotocin Nsc-178248), a new nitrosourea antitumor agent

1 reference

12 December 2020

Chlorozotocin: phase II evaluation in patients with advanced sarcomas

1 reference

12 December 2020

Phase II evaluation of chlorozotocin in metastatic sarcomas

1 reference

12 December 2020

Phase II evaluation of chlorozotocin (NSC-178248) in advanced human cancer

1 reference

12 December 2020

Experimental and clinical activity of mitomycin C and cis-diamminedichloroplatinum in malignant mesothelioma

1 reference

12 December 2020

Inhibition of the synthesis of polyamines and DNA in activated lymphocytes by a combination of alpha-methylornithine and methylglyoxal bis(guanylhydrazone).

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00170765

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:2417985%20AND%20SRC:MED&resulttype=core&format=json

28 September 2019

1 reference